Related references
Note: Only part of the references are listed.The CLK inhibitor SM08502 induces anti-tumor activity and reduces Wnt pathway gene expression in gastrointestinal cancer models
Betty Y. Tam et al.
CANCER LETTERS (2020)
Mechanism-Based Personalized Medicine for Cystic Fibrosis by Suppressing Pseudo Exon Inclusion
Saiko Shibata et al.
CELL CHEMICAL BIOLOGY (2020)
Structural basis of a small molecule targeting RNA for a specific splicing correction
Sebastien Campagne et al.
NATURE CHEMICAL BIOLOGY (2019)
Rescue of recurrent deep intronic mutation underlying cell type-dependent quantitative NEMO deficiency
Bertrand Boisson et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
ELP1 Splicing Correction Reverses Proprioceptive Sensory Loss in Familial Dysautonomia
Elisabetta Morini et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2019)
Ensembl 2018
Daniel R. Zerbino et al.
NUCLEIC ACIDS RESEARCH (2018)
Anti-tumor efficacy of a novel CLK inhibitor via targeting RNA splicing and MYC-dependent vulnerability
Kenichi Iwai et al.
EMBO MOLECULAR MEDICINE (2018)
Nusinersen versus Sham Control in Later-Onset Spinal Muscular Atrophy
E. Mercuri et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antisense oligonucleotides correct the familial dysautonomia splicing defect in IKBKAP transgenic mice
Rahul Sinha et al.
NUCLEIC ACIDS RESEARCH (2018)
UniProt: the universal protein knowledgebase (vol 45, pg D158, 2017)
Alexandre Renaux
NUCLEIC ACIDS RESEARCH (2018)
Systematic Analysis of Splice-Site-Creating Mutations in Cancer
Reyka G. Jayasinghe et al.
CELL REPORTS (2018)
Comprehensive Characterization of Cancer Driver Genes and Mutations (vol 173, 371.e1, 2018)
Matthew H. Bailey et al.
CELL (2018)
Discovery of Risdiplam, a Selective Survival of Motor Neuron-2 (SMN2) Gene Splicing Modifier for the Treatment of Spinal Muscular Atrophy (SMA)
Hasane Ratni et al.
JOURNAL OF MEDICINAL CHEMISTRY (2018)
SRPK1 maintains acute myeloid leukemia through effects on isoform usage of epigenetic regulators including BRD4
Konstantinos Tzelepis et al.
NATURE COMMUNICATIONS (2018)
SRPKIN-1: A Covalent SRPK1/2 Inhibitor that Potently Converts VEGF from Pro-angiogenic to Anti-angiogenic Isoform
John M. Hatcher et al.
CELL CHEMICAL BIOLOGY (2018)
The roles of RNA processing in translating genotype to phenotype
Kassie S. Manning et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2017)
The nuts and bolts of the endogenous spliceosome
Ruth Sperling
WILEY INTERDISCIPLINARY REVIEWS-RNA (2017)
Nusinersen versus Sham Control in Infantile-Onset Spinal Muscular Atrophy
R. S. Finkel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Prenatal neurogenesis induction therapy normalizes brain structure and function in Down syndrome mice
Akiko Nakano-Kobayashi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
RBM24 promotes U1 snRNP recognition of the mutated 5′ splice site in the IKBKAP gene of familial dysautonomia
Kenji Ohe et al.
RNA (2017)
Binding to SMN2 pre-mRNA-protein complex elicits specificity for small molecule splicing modifiers
Manaswini Sivaramakrishnan et al.
NATURE COMMUNICATIONS (2017)
A deep intronic CLRN1 (USH3A) founder mutation generates an aberrant exon and underlies severe Usher syndrome on the Arabian Peninsula
Arif O. Khan et al.
SCIENTIFIC REPORTS (2017)
IKBKAP/ELP1 gene mutations: mechanisms of familial dysautonomia and gene-targeting therapies
Berish Y. Rubin et al.
APPLICATION OF CLINICAL GENETICS (2017)
Variant Review with the Integrative Genomics Viewer
James T. Robinson et al.
CANCER RESEARCH (2017)
Development of Potent, Selective SRPK1 Inhibitors as Potential Topical Therapeutics for Neovascular Eye Disease
Jennifer Batson et al.
ACS CHEMICAL BIOLOGY (2017)
Ledipasvir-sofosbuvir in patients with hepatitis C virus genotype 5 infection: an open-label, multicentre, single-arm, phase 2 study
Armand Abergel et al.
LANCET INFECTIOUS DISEASES (2016)
Capturing the biology of disease severity in a PSC-based model of familial dysautonomia
Nadja Zeltner et al.
NATURE MEDICINE (2016)
Modulation of splicing catalysis for therapeutic targeting of leukemia with mutations in genes encoding spliceosomal proteins
Stanley Chun-Wei Lee et al.
NATURE MEDICINE (2016)
RNAseq analysis for the diagnosis of muscular dystrophy
Hernan Gonorazky et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2016)
Modulation of Alternative Splicing with Chemical Compounds in New Therapeutics for Human Diseases
Kenji Ohe et al.
ACS CHEMICAL BIOLOGY (2015)
Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis
So Masaki et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2015)
Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia
Mayumi Yoshida et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
Identification of a DYRK1A Inhibitor that Induces Degradation of the Target Kinase using Co-chaperone CDC37 fused with Luciferase nanoKAZ
Rie Sonamoto et al.
SCIENTIFIC REPORTS (2015)
Repbase Update, a database of repetitive elements in eukaryotic genomes
Weidong Bao et al.
MOBILE DNA (2015)
Deep intronic KRIT1 mutation in a family with clinically silent multiple cerebral cavernous malformations
F. Riant et al.
CLINICAL GENETICS (2014)
A phase I, open-label, single-arm, dose-escalation study of E7107, a precursor messenger ribonucleic acid (pre-mRNA) splicesome inhibitor administered intravenously on days 1 and 8 every 21 days to patients with solid tumors
D. S. Hong et al.
INVESTIGATIONAL NEW DRUGS (2014)
Context-dependent control of alternative splicing by RNA-binding proteins
Xiang-Dong Fu et al.
NATURE REVIEWS GENETICS (2014)
SMN2 splicing modifiers improve motor function and longevity in mice with spinal muscular atrophy
Nikolai A. Naryshkin et al.
SCIENCE (2014)
Phase I Pharmacokinetic and Pharmacodynamic Study of the First-in-Class Spliceosome Inhibitor E7107 in Patients with Advanced Solid Tumors
Ferry A. L. M. Eskens et al.
CLINICAL CANCER RESEARCH (2013)
Familial dysautonomia model reveals Ikbkap deletion causes apoptosis of Pax3+ progenitors and peripheral neurons
Lynn George et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Combined small-molecule inhibition accelerates developmental timing and converts human pluripotent stem cells into nociceptors
Stuart M. Chambers et al.
NATURE BIOTECHNOLOGY (2012)
NIH Image to ImageJ: 25 years of image analysis
Caroline A. Schneider et al.
NATURE METHODS (2012)
WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing
Elianna M. Amin et al.
CANCER CELL (2011)
Specific correction of a splice defect in brain by nutritional supplementation
Ranjit S. Shetty et al.
HUMAN MOLECULAR GENETICS (2011)
Frequent pathway mutations of splicing machinery in myelodysplasia
Kenichi Yoshida et al.
NATURE (2011)
Chemical treatment enhances skipping of a mutated exon in the dystrophin gene
Atsushi Nishida et al.
NATURE COMMUNICATIONS (2011)
Visualization and genetic analysis of alternative splicing regulation in vivo using fluorescence reporters in transgenic Caenorhabditis elegans
Hidehito Kuroyanagi et al.
NATURE PROTOCOLS (2010)
Splicing Reporter Mice Revealed the Evolutionally Conserved Switching Mechanism of Tissue-Specific Alternative Exon Selection
Akihide Takeuchi et al.
PLOS ONE (2010)
Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A
Yasushi Ogawa et al.
NATURE COMMUNICATIONS (2010)
Antisense masking of an hnRNP A1/A2 intronic splicing silencer corrects SMN2 splicing in Transgenic mice
Yimin Hua et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2008)
Alternative isoform regulation in human tissue transcriptomes
Eric T. Wang et al.
NATURE (2008)
Splicing factor SF3b as a target of the antitumor natural product pladienolide
Yoshihiko Kotake et al.
NATURE CHEMICAL BIOLOGY (2007)
A humanized IKBKAP transgenic mouse models a tissue-specific human splicing defect
Matthew M. Hims et al.
GENOMICS (2007)
Spliceostatin A targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA
Daisuke Kaida et al.
NATURE CHEMICAL BIOLOGY (2007)
Weak definition of IKBKAP exon 20 leads to aberrant splicing in familial dysautonomia
El Cherif Ibrahim et al.
HUMAN MUTATION (2007)
Allosteric activation of the protein kinase PDK1 with low molecular weight compounds
Matthias Engel et al.
EMBO JOURNAL (2006)
Transgenic alternative-splicing reporters reveal tissue-specific expression profiles and regulation mechanisms in vivo
Hidehito Kuroyanagi et al.
NATURE METHODS (2006)
Utilization of host SR protein kinases and RNA-splicing machinery during viral replication
Takeshi Fukuhara et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Comparative analysis detects dependencies among the 5′ splice-site positions
I Carmel et al.
RNA (2004)
Rescue of a human mRNA splicing defect by the plant cytokinin kinetin
SA Slaugenhaupt et al.
HUMAN MOLECULAR GENETICS (2004)
Manipulation of alternative splicing by a newly developed inhibitor of Clks
M Muraki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
ESEfinder: a web resource to identify exonic splicing enhancers
L Cartegni et al.
NUCLEIC ACIDS RESEARCH (2003)
Specific SR protein-dependent splicing substrates identified through genomic SELEX
S Kim et al.
NUCLEIC ACIDS RESEARCH (2003)
Survival in familial dysautonomia: Impact of early intervention
FB Axelrod et al.
JOURNAL OF PEDIATRICS (2002)
Listening to silence and understanding nonsense: Exonic mutations that affect splicing
L Cartegni et al.
NATURE REVIEWS GENETICS (2002)
Tissue-specific expression of a splicing mutation in the IKBKAP gene causes familial dysautonomia
SA Slaugenhaupt et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2001)
Share Paper
